Jeffries Oliver-Li's practice focuses on corporate and securities law matters. He represents companies in public offerings, venture capital financings and mergers and acquisitions. Mr. Oliver-Li also advises companies with respect to securities law compliance and disclosures and general corporate matters.

Mr. Oliver-Li's public company clients include Casa Systems, Catabasis Pharmaceuticals, Editas Medicine, EverQuote and PerkinElmer.

Mr. Oliver-Li's transactional practice has included representation of:

  • Casella Waste Systems, Inc. in its tender offer for and redemption of $195 million of senior subordinated notes;
  • Catabasis Pharmaceuticals, Inc. in its $69 million initial public offering;
  • Constellation Pharmaceuticals, Inc. in its $55 million mezzanine financing;
  • CoreStreet, Ltd. in its acquisition by ActivIdentity Corporation for $19 million;
  • Editas Medicine, Inc. in its $109 million initial public offering;
  • Netezza Corporation in its acquisition by IBM for $1.9 billion;
  • Sonus Networks, Inc. in its acquisition of Network Equipment Technologies, Inc. for $42 million;
  • Tangoe, Inc. in its $100 million initial public offering and its $170 million follow-on offering; and
  • Tetraphase Pharmaceuticals, Inc. in its $80 million initial public offering.

While in law school, Mr. Oliver-Li held a summer associate position with WilmerHale, working primarily in corporate law and litigation.

Insights & News

Credentials

  • Education

    • JD, Harvard Law School, 2006

      cum laude Harvard Journal of Law & Technology
    • AB, History of Art & Architecture, Harvard College, 2003

      summa cum laude Phi Beta Kappa, Thomas Temple Hoopes Prize
  • Admissions

    • Massachusetts

    • Colorado

Credentials

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.